PPCB offering history
Every offering-related filing in Propanc Biopharma, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 431 filings back to Jun 23, 2011.
| Date | Filing | What it means | |
|---|---|---|---|
| Jul 27, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 17, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Apr 20, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 10, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 6, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 24, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 19, 2026 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 2, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jan 30, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 9, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 30, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Nov 10, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 18, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 18, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 13, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 30, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 28, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 22, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 27, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 18, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 2, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 30, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 8, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 25, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 21, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 8, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 2, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 31, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 18, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 12, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 20, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 30, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Sep 27, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 15, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 7, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 2, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 21, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 12, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 5, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 22, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
PPCB offering FAQ
When did PPCB last execute an offering?
Per SEC filings, Propanc Biopharma, Inc.'s most recent priced offering document is a 8-K filed 2025-11-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did PPCB last announce or register an offering?
The most recent registration is a S-1 filed 2026-07-17. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.